Product Code: MRFR/MED/2123-CR
Medical devises Market Forecast to 2030
Market Overview
The medical devices market is expected to register a CAGR of 6.99% during the estimated time frame.
In contrast to drugs or biologics, medical devices accomplish their objectives through the physical, underlying, or mechanical activity as opposed to synthetic or metabolic activity inside or on the body. Straightforward, generally safe (Class-I) devices like tongue depressors, medical thermometers, dispensable gloves, and chamber pots are models, as are mind-boggling, high-risk (Class-II) devices that are embedded and drag out life.
The rising pervasiveness of persistent circumstances and the treatment of patients experiencing these sicknesses is applying tremendous strain on the medical care frameworks of numerous nations. The general expenses of treating a patient in a clinic ongoing setting are essentially higher, and longer emergency clinic stays are related to a higher monetary weight. In this manner, with the endeavors taken by medical services organizations to move patients towards home consideration settings, additionally, market players are effectively putting resources into innovative work of cutting edge and simple to-utilize medical hardware, for example, particular beds, individual lifting, and moving gear, and toileting helps for the therapy of constant sicknesses.
Market Segmentation
Worldwide Medical Devices Market is divided, by Device Type, Applications, End-User, and Regions.
In view of type, the market is grouped into Medication Conveyance Frameworks, Obtrusive Devices, Analytic Devices, Respiratory Restorative Devices, Electronic Medical Devices, and others.
The sub-division is as per the following.
- Drug Delivery System
- Metered Dose Inhaler Devices
- Infusion Systems
- Others
- Diagnostic Devices
- Laboratory-Based Diagnostic Devices
§ X-Ray
§ CT (Computed Tomography)
§ PET (Positron Emission Tomography)
§ Others
- Wearable Diagnostic Devices
§ Vital Signs Monitors
§ Fetal and Obstetric Monitoring Devices
§ Others
- Invasive Devices
- Implants and Stimulation Devices
- Defibrillators
- Pacemakers
- Others
- Respiratory Therapeutic Devices
- Ventilators
- Oxygen Concentrators
- Resuscitators
- Others
- Electronic Medical Device
§ Sphygmomanometer
§ Pulse Oximeter
§ Digital Thermometers
§ Brain Wave Mete
§ Electrocardiogram Meter
§ Body Fat Meter
§ Bone Density Meter
§ Physiological Monitoring System
§ Others
- Massage Chairs
- Heating Blankets
- Electronical Hospital Beds
- Others
- Others
In view of Application, the market is grouped into Demonstrative Imaging, Cardiovascular Sicknesses, Muscular health. Ophthalmology, Nervous system science, Oncology, General medical procedure, Respiratory, Dental, ENT, Nephrology and Urology, and others.
The End User industry is comprised of Emergency clinics and Facilities, Walking Careful Focuses, Homecare Settings, and Others.
Regional Analysis
North America accounted biggest market share in Medical Devices Market. This is credited to the rising predominance of ongoing sicknesses like a malignant growth, cardiovascular problems, diabetes, Persistent Obstructive Aspiratory Infection (COPD), Alzheimer's, heftiness, and joint inflammation among others. Asia-Pacific is viewed as the quickest-developing medical devices market.
Major Players
The Key Companies Covered in this Report by Johnson & Johnson Services Inc (US), Fresenius SE & Co. KGaA (Germany), Abbott (US), GE Healthcare (US), Siemens AG (Germany), Stryker (US), Becton, Dickinson, and Company (US), Medtronic (Ireland), Boston Scientific Corporation (US), and Bio-Rad Laboratories, Inc (US).
TABLE OF CONTENTS
LIST OF CONTENTS
1 EXECUTIVE SUMMARY 19
2 MARKET INTRODUCTION 21
- 2.1 DEFINITION 21
- 2.2 SCOPE OF THE STUDY 21
- 2.3 RESEARCH OBJECTIVE 21
- 2.4 MARKET STRUCTURE 22
- 2.5 ASSUMPTIONS & LIMITATIONS 22
3 RESEARCH METHODOLOGY 23
- 3.1 DATA MINING 23
- 3.2 SECONDARY RESEARCH 24
- 3.3 PRIMARY RESEARCH 24
- 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 25
- 3.5 FORECASTING TECHNIQUES 26
- 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 27
- 3.6.1 BOTTOM-UP APPROACH 28
- 3.6.2 TOP-DOWN APPROACH 28
- 3.7 DATA TRIANGULATION 29
- 3.8 VALIDATION 29
4 MARKET DYNAMICS 30
- 4.1 OVERVIEW 30
- 4.2 DRIVERS 31
- 4.2.1 SHIFT TOWARDS HOMECARE SETTINGS IS BOOSTING THE DEMAND FOR PORTABLE DEVICES 31
- 4.2.2 INCREASING TECHNOLOGICAL ADVANCEMENT 31
- 4.2.3 RISING PREVALENCE OF CHRONIC DISEASES BOOSTS THE DEMAND FOR MEDICAL DEVICES 31
- 4.3 RESTRAINTS 32
- 4.3.1 HIGH COST OF MEDICAL DEVICES 32
- 4.3.2 THREAT TO DATA SECURITY &STRICT REGULATORY COMPLIANCE 32
- 4.4 OPPORTUNITIES 33
- 4.4.1 INCREASING RESEARCH & DEVELOPMENT INVESTMENT 33
5 MARKET FACTOR ANALYSIS 34
- 5.1 VALUE CHAIN ANALYSIS 34
- 5.1.1 R&D AND DESIGNING 35
- 5.1.2 MANUFACTURING 35
- 5.1.3 DISTRIBUTION & SALES 35
- 5.1.4 POST-SALES SERVICES 35
- 5.2 PORTER'S FIVE FORCES MODEL 36
- 5.2.1 THREAT OF NEW ENTRANTS 36
- 5.2.2 BARGAINING POWER OF SUPPLIERS 36
- 5.2.3 THREAT OF SUBSTITUTES 37
- 5.2.4 BARGAINING POWER OF BUYERS 37
- 5.2.5 INTENSITY OF RIVALRY 37
- 5.3 IMPACT OF COVID-19 ON THE MEDICAL DEVICE MARKET 37
- 5.3.1 IMPACT ON THE SUPPLY CHAIN 37
- 5.3.2 IMPACT ON PRODUCTION 37
- 5.3.3 IMPACT ON REGIONS 38
- 5.3.4 DEMAND-SUPPLY GAP ANALYSIS 38
- 5.3.5 IMPACT ON PRICING 38
- 5.4 ROBOTICS USED IN HEALTHCARE MANUFACTURING PROCESSES 38
6 GLOBAL MEDICAL DEVICES MARKET, BY DEVICE TYPE 39
- 6.1 OVERVIEW 39
- 6.2 DRUG DELIVERY SYSTEMS 40
- 6.2.1 METERED DOSE INHALER DEVICES 41
- 6.2.2 INFUSION SYSTEMS 43
- 6.2.3 OTHERS 43
- 6.3 DIAGNOSTIC DEVICES 43
- 6.3.1 LABORATORY BASED DIAGNOSTIC DEVICES 45
- 6.3.1.1 X-RAY 46
- 6.3.1.2 COMPUTED TOMOGRAPHY (CT) 46
- 6.3.1.3 POSITRON EMISSION TOMOGRAPHY (PET) 46
- 6.3.1.4 OTHERS 47
- 6.3.2 WEARABLE DIAGNOSTIC DEVICES 47
- 6.3.2.1 VITAL SIGNS MONITORS 48
- 6.3.2.2 FETAL AND OBSTETRIC MONITORING DEVICES 48
- 6.3.2.3 OTHERS 48
- 6.3.3 OTHERS 49
- 6.4 INVASIVE DEVICES 49
- 6.4.1 IMPLANTS AND STIMULATION DEVICES 50
- 6.4.2 DEFIBRILLATORS 52
- 6.4.3 PACEMAKERS 52
- 6.4.4 OTHERS 52
- 6.5 RESPIRATORY THERAPEUTIC DEVICES 53
- 6.5.1 VENTILATORS 54
- 6.5.2 OXYGEN CONCENTRATORS 54
- 6.5.3 RESUSCITATORS 55
- 6.5.4 OTHERS 55
- 6.6 ELECTRONIC MEDICAL DEVICE 55
- 6.6.1 MONITORING DEVICES 57
- 6.6.1.1 SPHYGMOMANOMETER 58
- 6.6.1.2 PULSE OXIMETER 58
- 6.6.1.3 DIGITAL THERMOMETERS 58
- 6.6.1.4 BRAIN WAVE METE 59
- 6.6.1.5 ELECTROCARDIOGRAM METER 59
- 6.6.1.6 BODY FAT METER 59
- 6.6.1.7 BONE DENSITY METER 60
- 6.6.1.8 PHYSIOLOGICAL MONITORING SYSTEM 60
- 6.6.1.9 OTHERS 60
- 6.6.2 MASSAGE CHAIRS 61
- 6.6.3 HEATING BLANKETS 61
- 6.6.4 ELECTRONICAL HOSPITAL BEDS 61
- 6.6.5 OTHERS 62
- 6.7 OTHERS 62
7 GLOBAL MEDICAL DEVICES MARKET, BY APPLICATION 63
- 7.1 OVERVIEW 63
- 7.2 CARDIOVASCULAR DISEASES 65
- 7.3 DIAGNOSTIC IMAGING 65
- 7.4 ORTHOPEDICS 66
- 7.5 ONCOLOGY 66
- 7.6 OPHTHALMOLOGY 67
- 7.7 GENERAL SURGERY 67
- 7.8 RESPIRATORY 68
- 7.9 DENTAL 68
- 7.10 ENT 69
- 7.11 NEUROLOGY 69
- 7.12 NEPHROLOGY & UROLOGY 70
- 7.13 OTHERS 70
8 GLOBAL MEDICAL DEVICES MARKET, BY END USER 71
- 8.1 OVERVIEW 71
- 8.2 HOSPITALS & CLINICS 72
- 8.3 AMBULATORY SURGICAL CENTERS 73
- 8.4 HOMECARE SETTINGS 73
- 8.5 OTHERS 74
9 GLOBAL MEDICAL DEVICES MARKET, BY REGION 75
- 9.1 OVERVIEW 75
- 9.2 NORTH AMERICA 77
- 9.2.1 US 82
- 9.2.2 CANADA 87
- 9.3 EUROPE 92
- 9.3.1 GERMANY 99
- 9.3.2 UK 104
- 9.3.3 FRANCE 108
- 9.3.4 ITALY 112
- 9.3.5 SPAIN 116
- 9.3.6 REST OF EUROPE 121
- 9.4 ASIA-PACIFIC 126
- 9.4.1 JAPAN 133
- 9.4.2 CHINA 138
- 9.4.3 INDIA 143
- 9.4.4 AUSTRALIA 148
- 9.4.5 SOUTH KOREA 154
- 9.4.6 REST OF ASIA-PACIFIC 160
- 9.5 REST OF THE WORLD 167
- 9.5.1 MIDDLE EAST 173
- 9.5.2 AFRICA 179
- 9.5.3 LATIN AMERICA 184
10 COMPETITIVE LANDSCAPE 190
- 10.1 OVERVIEW 191
- 10.2 COMPETITIVE BENCHMARKING 192
- 10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL EPILEPSY DEVICES MARKET 193
- 10.4 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN GLOBAL MEDICAL DEVICES MARKET 194
- 10.5 KEY DEVELOPMENTS & GROWTH STRATEGIES 195
- 10.5.1 PRODUCT LAUNCH 195
- 10.5.2 COLLABORATION 195
- 10.5.3 AGREEMENT 195
- 10.5.4 ACQUISITION 195
- 10.5.5 PARTNERSHIP 195
- 10.6 MAJOR PLAYERS FINANCIAL MATRIX 195
- 10.6.1 SALES (USD MILLION), 2021 195
- 10.6.2 R&D (USD MILLION), 2021 196
11 COMPANY PROFILE 197
- 11.1 ABBOTT 197
- 11.1.1 COMPANY OVERVIEW 197
- 11.1.2 FINANCIAL OVERVIEW 198
- 11.1.3 PRODUCTS OFFERED 199
- 11.1.4 KEY DEVELOPMENTS 199
- 11.1.5 SWOT ANALYSIS 200
- 11.1.6 KEY STRATEGIES 200
- 11.2 FRESENIUS SE & CO. KGAA 201
- 11.2.1 COMPANY OVERVIEW 201
- 11.2.2 FINANCIAL OVERVIEW 201
- 11.2.3 PRODUCTS OFFERED 202
- 11.2.4 KEY DEVELOPMENTS 202
- 11.2.5 SWOT ANALYSIS 203
- 11.2.6 KEY STRATEGIES 203
- 11.3 GE HEALTHCARE 204
- 11.3.1 COMPANY OVERVIEW 204
- 11.3.2 FINANCIAL OVERVIEW 204
- 11.3.3 PRODUCTS OFFERED 205
- 11.3.4 KEY DEVELOPMENTS 209
- 11.3.5 SWOT ANALYSIS 209
- 11.3.6 KEY STRATEGIES 209
- 11.4 JOHNSON & JOHNSON SERVICES INC. 210
- 11.4.1 COMPANY OVERVIEW 210
- 11.4.2 FINANCIAL OVERVIEW 210
- 11.4.3 PRODUCTS OFFERED 211
- 11.4.4 KEY DEVELOPMENTS 211
- 11.4.5 SWOT ANALYSIS 212
- 11.4.6 KEY STRATEGIES 212
- 11.5 MEDTRONIC 213
- 11.5.1 COMPANY OVERVIEW 213
- 11.5.2 FINANCIAL OVERVIEW 213
- 11.5.3 PRODUCTS OFFERED 214
- 11.5.4 KEY DEVELOPMENTS 215
- 11.5.5 SWOT ANALYSIS 215
- 11.5.6 KEY STRATEGIES 216
- 11.6 SIEMENS 217
- 11.6.1 COMPANY OVERVIEW 217
- 11.6.2 FINANCIAL OVERVIEW 217
- 11.6.3 PRODUCTS OFFERED 218
- 11.6.4 KEY DEVELOPMENTS 220
- 11.6.5 KEY STRATEGIES 220
- 11.7 STRYKER 221
- 11.7.1 COMPANY OVERVIEW 221
- 11.7.2 FINANCIAL OVERVIEW 221
- 11.7.3 PRODUCTS OFFERED 222
- 11.7.4 KEY DEVELOPMENTS 222
- 11.7.5 KEY STRATEGIES 222
- 11.8 BOSTON SCIENTIFIC CORPORATION 223
- 11.8.1 COMPANY OVERVIEW 223
- 11.8.2 FINANCIAL OVERVIEW 223
- 11.8.3 PRODUCTS OFFERED 224
- 11.8.4 KEY DEVELOPMENTS 225
- 11.8.5 KEY STRATEGIES 225
- 11.9 BECTON, DICKINSON AND COMPANY 226
- 11.9.1 COMPANY OVERVIEW 226
- 11.9.2 FINANCIAL OVERVIEW 227
- 11.9.3 PRODUCTS OFFERED 228
- 11.9.4 KEY DEVELOPMENTS 228
- 11.9.5 KEY STRATEGIES 228
- 11.10 BIO-RAD LABORATORIES, INC. 229
- 11.10.1 COMPANY OVERVIEW 229
- 11.10.2 FINANCIAL OVERVIEW 229
- 11.10.3 PRODUCTS OFFERED 230
- 11.10.4 KEY DEVELOPMENTS 230
- 11.10.5 KEY STRATEGIES 230
12 APPENDIX 231
- 12.1 REFERENCES 231
- 12.2 RELATED REPORTS 232